Introduction
Onychomycosis, commonly known as fungal nail infection, is a prevalent condition in foot health practice, affecting up to 10% of the general population and often leading to nail discoloration, thickening, and brittleness (Westerberg and Voyack, 2013). However, several other nail disorders can mimic its clinical features, potentially leading to misdiagnosis and inappropriate treatment. This essay, from the perspective of a foot health practitioner student, selects nail psoriasis as a comparable condition due to its similar manifestations, such as onycholysis and subungual debris. The purpose is to outline the differences in presentation and management between onychomycosis and nail psoriasis, drawing on evidence-based sources to inform clinical decision-making. Key points include variations in symptoms, diagnostic approaches, and therapeutic strategies, highlighting the need for accurate differentiation to optimise patient outcomes.
Presentation of Onychomycosis
Onychomycosis typically presents with gradual changes in nail appearance and structure, often starting at the distal or lateral edges of the nail. Common features include yellow or white discoloration, nail plate thickening (hyperkeratosis), brittleness, and the accumulation of subungual debris, which can cause the nail to lift from the bed (onycholysis) (Westerberg and Voyack, 2013). It is predominantly caused by dermatophytes like Trichophyton rubrum, and risk factors include diabetes, immunosuppression, and occlusive footwear, which are frequently encountered in podiatric settings. Indeed, the condition may affect multiple nails, particularly toenails, and can lead to secondary bacterial infections if untreated. Diagnosis often relies on clinical examination supplemented by laboratory tests, such as potassium hydroxide (KOH) microscopy or fungal culture, to confirm the presence of fungal elements (Elewski, 1998).
Presentation of Nail Psoriasis
Nail psoriasis, a manifestation of the chronic inflammatory skin disorder psoriasis, affects approximately 50-80% of individuals with cutaneous psoriasis and can occur independently (Rich and Scher, 2005). It commonly features nail pitting (small depressions on the nail surface), onycholysis, subungual hyperkeratosis, and splinter haemorrhages, often accompanied by oil-drop discoloration (salmon patches). Typically, these changes are bilateral and may involve fingernails as well as toenails, with symptoms fluctuating in severity alongside skin plaques. As a systemic condition, it is linked to immune-mediated inflammation, and patients may report associated joint pain (psoriatic arthritis) or a family history of psoriasis. Diagnosis is primarily clinical, based on the overall pattern and correlation with skin involvement, though biopsy is rarely needed unless malignancy is suspected (Baran and de Berker, 2012).
Differences in Presentation
While both conditions exhibit overlapping signs like onycholysis and hyperkeratosis, key differences aid differentiation. Onychomycosis often shows a more uniform discoloration (e.g., yellow-brown streaks) and distal involvement, progressing slowly without pitting, which is a hallmark of nail psoriasis (Rich and Scher, 2005). Psoriasis-related changes, however, frequently include multiple nail matrix abnormalities, such as pitting and oil spots, and are more likely to affect all nails symmetrically, arguably reflecting its inflammatory aetiology. Furthermore, onychomycosis debris is typically friable and odorous due to fungal activity, whereas psoriatic hyperkeratosis is denser and less malodorous. These distinctions are crucial in foot health practice, as misidentifying psoriasis as a fungal infection could delay appropriate referral to dermatology.
Differences in Management
Management strategies diverge significantly based on aetiology. For onychomycosis, treatment focuses on antifungal therapies, such as oral terbinafine or topical amorolfine, with a typical course of 3-6 months and emphasis on foot hygiene to prevent recurrence (Westerberg and Voyack, 2013). In contrast, nail psoriasis management involves topical corticosteroids, vitamin D analogues (e.g., calcipotriol), or systemic biologics for severe cases, often requiring multidisciplinary input from rheumatology if arthritis is present (Baran and de Berker, 2012). While both may benefit from nail trimming and emollients in podiatric care, antifungal agents are ineffective for psoriasis and could lead to unnecessary side effects. Therefore, accurate diagnosis through microscopy or dermatological consultation is essential to tailor interventions effectively.
Conclusion
In summary, although onychomycosis and nail psoriasis share features like onycholysis and thickening, differences in presentation—such as pitting in psoriasis versus fungal debris in onychomycosis—and management—antifungals versus anti-inflammatory therapies—underscore the importance of precise assessment in foot health practice. These insights highlight the limitations of clinical observation alone and the value of laboratory confirmation to avoid treatment errors. For aspiring practitioners, this knowledge enhances problem-solving in complex cases, ultimately improving patient care and reducing the burden of chronic nail disorders. Implications include the need for ongoing education on differential diagnoses to address diagnostic challenges in diverse patient populations.
References
- Baran, R. and de Berker, D. (2012) Baran & Dawber’s Diseases of the Nails and their Management. 4th edn. Wiley-Blackwell.
- Elewski, B.E. (1998) ‘Onychomycosis: Pathogenesis, Diagnosis, and Management’, Clinical Microbiology Reviews, 11(3), pp. 415-429. Available at: https://journals.asm.org/doi/10.1128/CMR.11.3.415.
- Rich, P. and Scher, R.K. (2005) ‘Nail Psoriasis Severity Index: A Useful Tool for Evaluation of Nail Psoriasis’, Journal of the American Academy of Dermatology, 53(2), pp. 206-212.
- Westerberg, D.P. and Voyack, M.J. (2013) ‘Onychomycosis: Current Trends in Diagnosis and Treatment’, American Family Physician, 88(11), pp. 762-770. Available at: https://www.aafp.org/pubs/afp/issues/2013/1201/p762.html.
(Word count: 812)
